Opinion · 22 Oct 2024
Conference abstractPublished 2018
Polymer system targeted with oligopeptides simultaneously useful for fluorescence-guided endoscopic surgery and targeted tumor therapy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The polymer carrier based on poly(N-(2-hydroxypropyl) methacrylamide) labeled with a fluorescent dye Dyomics 633 and targeted with oligopeptides GE-7 or GE-11 was designed, synthesized and characterized. Both peptides are specific targeting ligands binding to epidermal growth factor receptor that is overexpressed on surface of many tumor cells. The targeting peptide sequences were attached to the polymer backbone using a “click” reaction between the N-terminal azide group of the peptide and dibenzocyclooctyne group attached to the polymer precursor. The fluorescent polymer-peptide conjugate was designed primarily as a diagnostic tool for a successful fluorescence-guided endoscopic surgery. Specific accumulation of the polymer system in the tumor mass is accompanied with the fluorescence signal from the malignant cells, which enables more precise resection of the tumor without damaging the heathy tissue. Moreover, replacement of the fluorescent dye with a cytostatic drug provides a targeted polymer system used for advanced treatment of the neoplastic diseases. Flow cytometry was used for examination of the binding efficacy of the oligopeptide-targeted conjugates to epidermal growth factor receptor (EGFR) on the cell membranes of the malignant cells. The results showed that the highest binging efficacy was achieved with polymers bearing GE-11 targeting oligopeptide reaching to 146% of the binding of the control polymers with a scrambled peptide in human hypopharyngeal carcinoma cells (FaDu) and to 250% in human breast adenocarcinoma cells (MDA-MB-231). The polymer conjugates targeted with oligopeptides GE-7 or GE-11 can be used as materials with multiple functions as confirmed by in vitro experiments using flow cytometry and confocal microscopy.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. EuroSciCon does not store it.
More from this journal
The newest in International Journal of Drug Development and Research.
Opinion · 22 Oct 2024
From Monoclonal Antibodies to CAR-T Therapy: Trends and Transformations in Cancer Treatment
Perspective · 21 Oct 2024
Natural Products in Drug Discovery: From Traditional Remedies to Modern Medicines
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInternational Journal of Drug Development and Research
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Robert Pola”
- BylineArticles whose byline prints “E Bohmova”
- BylineArticles whose byline prints “K Zuska”
- BylineArticles whose byline prints “M Filipova”
- BylineArticles whose byline prints “J Parnica”
- BylineArticles whose byline prints “M Pechar”
- BylineArticles whose byline prints “J Boucek”
- BylineArticles whose byline prints “O Janouskova”
